Quarterly report · Q2
4572.TEDINET S100RGZ5
Period2023-01-01 → 2023-06-30
Filed2023-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥501m | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥1.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥840m | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | −¥864m | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | −¥312m | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | −¥868m | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥1.3bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥306m | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥869m | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥349m | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥886m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.3bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥359m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥886m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | −¥359m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥4.6bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥4.3bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥5.2bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥453m | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥625m | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.1bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥3.6bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥4.4bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.7bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.4bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.7bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.7bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.8bn | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥939m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥708m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥585m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥7m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥126m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥57m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.2bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥367m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥166m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-53.81 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.46 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-99.1 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-26.53 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-25.25 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 89.9% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.7% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 10
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥1.0bn |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥501m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥501m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥169m |
| jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥286m |
| jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥286m |
| jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥547m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥553m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥553m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥235m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 424
| Item | Context | Value | Unit |
|---|---|---|---|
| Deferred gains or losses on hedges | Prior1YearInstant | 615000 | JPY |
| Deferred gains or losses on hedges | CurrentQuarterInstant | － | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 33225000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 58399000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 31467000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 55685000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 17388000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 7999000 | JPY |
| Net assets | Prior1YearInstant | 3641844000 | JPY |
| Net assets | CurrentQuarterInstant | 4111801000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 4266453000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 4565118000 | JPY |
| Net sales | Prior1YTDDuration | 839543000 | JPY |
| Net sales | CurrentYTDDuration | 500570000 | JPY |
| Cost of sales | Prior1YTDDuration | 83078000 | JPY |
| Cost of sales | CurrentYTDDuration | 82684000 | JPY |
| Gross profit | Prior1YTDDuration | 756465000 | JPY |
| Gross profit | CurrentYTDDuration | 417886000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 1068482000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 1281582000 | JPY |
| Operating income | Prior1YTDDuration | -312016000 | JPY |
| Operating income | CurrentYTDDuration | -863696000 | JPY |
| Interest income noi | Prior1YTDDuration | 57000 | JPY |
| Interest income noi | CurrentYTDDuration | 84000 | JPY |
| Dividends income noi | Prior1YTDDuration | 204000 | JPY |
| Dividends income noi | CurrentYTDDuration | 211000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 7918000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 2029000 | JPY |
| Other noi | Prior1YTDDuration | 2396000 | JPY |
| Other noi | CurrentYTDDuration | 104000 | JPY |
| Non operating income | Prior1YTDDuration | 10576000 | JPY |
| Non operating income | CurrentYTDDuration | 2430000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 3063000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 1695000 | JPY |
| Guarantee commission noe | Prior1YTDDuration | 492000 | JPY |
| Guarantee commission noe | CurrentYTDDuration | 477000 | JPY |
| Stock issuance cost noe | Prior1YTDDuration | 1434000 | JPY |
| Stock issuance cost noe | CurrentYTDDuration | 4966000 | JPY |
| Non operating expenses | Prior1YTDDuration | 4991000 | JPY |
| Non operating expenses | CurrentYTDDuration | 7139000 | JPY |
| Ordinary income | Prior1YTDDuration | -306431000 | JPY |
| Ordinary income | CurrentYTDDuration | -868405000 | JPY |
| Impairment loss el | Prior1YTDDuration | 42948000 | JPY |
| Impairment loss el | CurrentYTDDuration | 984000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 42948000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 984000 | JPY |
| Income before income taxes | Prior1YTDDuration | -349379000 | JPY |
| Income before income taxes | CurrentYTDDuration | -869389000 | JPY |
| Income taxes current | Prior1YTDDuration | 9802000 | JPY |
| Income taxes current | CurrentYTDDuration | 16275000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |